Increased topoisomerase IIα expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis
作者： Alan Coss , Miriam Tosetto , Edward J. Fox , Beata Sapetto-Rebow , Sheeona Gorman
DOI: 10.1016/J.CANLET.2008.11.018
关键词: Etoposide 、 Cell cycle 、 Fluorescence in situ hybridization 、 Molecular biology 、 Proliferation index 、 Irinotecan 、 Chromosome instability 、 Chemotherapy 、 Apoptosis 、 Biology
摘要: … color planes; Cy3, Cy5, and DAPI. Following subtraction of … Fluorescence mounting medium (30 μl) containing DAPI was … at 385 nm for DAPI, 488 nm for FITC and 543 for TRITC. Z-…
lenus.ie
elsevier.com
sci-hub.se 参考文章(42)
JEAN THIOULOUSE, DANIEL CHESSEL, SYLVAIN DOLE´DEC, JEAN-MICHEL OLIVIER, ADE-4: a multivariate analysis and graphical display software Statistics and Computing. ,vol. 7, pp. 75- 83 ,(1997) , 10.1023/A:1018513530268
Dominic A. Scudiero, Nicole Vigna, Ed Sausville, John C. Reed, Ingo Tamm, Tilman Oltersdorf, Yan Wang, IAP-Family Protein Survivin Inhibits Caspase Activity and Apoptosis Induced by Fas (CD95), Bax, Caspases, and Anticancer Drugs Cancer Research. ,vol. 58, pp. 5315- 5320 ,(1998)
Sheridan Henness, Mary W Davey, Rozelle M Harvie, Ross A Davey, Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIα expression International Journal of Radiation Oncology Biology Physics. ,vol. 54, pp. 895- 902 ,(2002) , 10.1016/S0360-3016(02)03037-7
Udo Kellner, Maxwell Sehested, Peter B Jensen, Frank Gieseler, Pierre Rudolph, Culprit and victim -- DNA topoisomerase II. Lancet Oncology. ,vol. 3, pp. 235- 243 ,(2002) , 10.1016/S1470-2045(02)00715-5
Eleanor J. Davison, Patrick S. Tarpey, Heike Fiegler, Ian P. M. Tomlinson, Nigel P. Carter, Deletion at chromosome band 20p12.1 in colorectal cancer revealed by high resolution array comparative genomic hybridization Genes, Chromosomes and Cancer. ,vol. 44, pp. 384- 391 ,(2005) , 10.1002/GCC.20252
Lazaris A., Kavantzas N., Zorzos H., Tsavaris N., Davaris P., Markers of drug resistance in relapsing colon cancer. Journal of Cancer Research and Clinical Oncology. ,vol. 128, pp. 114- 118 ,(2002) , 10.1007/S00432-001-0310-5
A H Arnaout, P M Dawson, S Soomro, P Taylor, N A Theodorou, M Feldmann, B M Fendly, H M Shepard, S Shousha, HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies. Journal of Clinical Pathology. ,vol. 45, pp. 726- 727 ,(1992) , 10.1136/JCP.45.8.726
Lin Huang, Miki Shitashige, Reiko Satow, Kazufumi Honda, Masaya Ono, Jisoo Yun, Akihiro Tomida, Takashi Tsuruo, Setsuo Hirohashi, Tesshi Yamada, Functional Interaction of DNA Topoisomerase IIα With the β-Catenin and T-Cell Factor-4 Complex Gastroenterology. ,vol. 133, pp. 1569- 1578 ,(2007) , 10.1053/J.GASTRO.2007.08.011
S Houlbrook, CM Addison, SL Davies, J Carmichael, IJ Stratford, AL Harris, ID Hickson, Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines British Journal of Cancer. ,vol. 72, pp. 1454- 1461 ,(1995) , 10.1038/BJC.1995.529
Haralampos S. Zorzos, Andreas C. Lazaris, Penelope A. Korkolopoulou, Nikolaos G. Kavantzas, Sofia Tseleni-Balafouta, Efstratios S. Patsouris, Nikolaos V. Tsavaris, Panagiotis S. Davaris, Multidrug resistance proteins and topoisomerase IIα expression in colon cancer: association with metastatic potential Pathology. ,vol. 35, pp. 315- 318 ,(2003) , 10.1080/0031302031000150524